SCHEMBL7965309

SCHEMBL7965309

NC(=O)Cc1cn(Cc2ccccc2)c2ccc(O)cc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 9/20 1.00
ICMT O60725 11/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004159 0.90 PLA2G2A (0.81) PLA2G2AICMT
SCHEMBL27364905 0.88 PLA2G2A (0.78) PLA2G2AICMT
SCHEMBL8289938 0.85 PLA2G2A (0.74) PLA2G2AICMT
SCHEMBL7963252 0.83 PLA2G2A (1.00) PLA2G2AICMT
SCHEMBL2008743 0.83 PLA2G2A (0.70) PLA2G2AICMT
SCHEMBL2005762 0.82 PLA2G2A (0.70) PLA2G2AICMT
SCHEMBL29043456 0.82 PLA2G2A (0.69) PLA2G2AICMT
SCHEMBL8924302 0.81 PLA2G2A (0.68) PLA2G2AICMT
SCHEMBL8926516 0.81 PLA2G2A (0.72) PLA2G2AICMT
SCHEMBL8178172 0.79 PLA2G2A (0.70) PLA2G2AICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252084-B1 THERAPY FOR SEPSIS SHOCK ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0620215-B1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors LILLY CO ELI (US) 1999-08-18 EP disclosed
US-5684034-A INHIBITORS OF HUMAN NON-PANCREATIC SECRETORY PHOSPHOLIPASE A2, TREATMENT OF SEPTIC SHOCK, TRAUMA, RESPIRATORY DISORDERS, RHEUMATIC ARTHRITIS, INHIBITORS OF ARACHIDONIC ACID RELEASE ELI LILLY AND COMPANY (US) 1997-11-04 US disclosed
EP-0620215-A1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed